| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0009 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.52 | 0.001 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.19 | 0.002 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |